Aaqib М. va boshq., Amerika terapiya jurnali 29(3):p e322-e333, May/Iyun 2022. | DOI: 10.1097/MJT.0000000000000925.Kirish: Sakubitril / valsartan...
Echocardiographic Markers in the Diagnosis of Cardiac Masses
Paolisso P., et al, Journal of the American Society of Echocardiography, Published: January 04, 2023DOI:https://doi.org/10.1016/j.echo.2022...
Long-Term Clinical Outcomes in Patients With Severe Tricuspid Regurgitation
Ref: Nishiura N., et al, J Am Heart Assoc. 2023;12:e025751. DOI: 10.1161/JAHA.122.025751BACKGROUND: The natural history and optimal interve...
Chronic HF poses additional mortality threat for patients with COVID-19
cardiology today, 7th Jan 2023, Adapted from Arutyunov GP, et al. ESC Heart Fail. 2022; doi:10.1002/ehf2.14243.Hospitalized patients with COVID-1...
Autoimmune disorders associated with AF risk
cardiology today, 8th Jan 2023 Adapted from: Tilly MJ, et al. Europace. 2022;doi:10.1093/europace/euac244Autoimmune disorders were associated wit...
Efficacy of Sacubitril/Valsartan in Hypertension
Aaqib M., et al, American Journal of Therapeutics 29(3):p e322-e333, May/June 2022. | DOI: 10.1097/MJT.0000000000000925.Background: Sacubit...
Cardiovascular and renal effects of SGLT2 inhibitor initiation in acute heart failure: a meta-analysis of randomized controlled trials
1.Carvalho P. et al, Clinical Research in Cardiology, Received: 22 September 2022 / Accepted: 21 December 2022 , Published online 2 Jan 2023, htt...